Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

USANA HEALTH SCIENCES, INC.

(USNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

USANA Health Sciences Seeks Acquisitions

07/28/2021 | 11:00am EDT

USANA Health Sciences, Inc. (NYSE:USNA) is looking for acquisitions. Chief Executive Officer and Chairman of the Board, Kevin Guest, said "we continue to execute this strategy, we will focus on improving our technology, launching new products and product lines, driving growth opportunities in existing markets, pursuing international expansion opportunities and capitalizing on business development opportunities, including strategic investments and acquisitions".


© S&P Capital IQ 2021
All news about USANA HEALTH SCIENCES, INC.
09/16USANA HEALTH SCIENCES : Scales Back 2021 Revenue, Earnings Outlook -- Shares Dro..
MT
09/16GUIDANCE : (USNA) USANA HEALTH SCIENCES Sees Q3 Revenue Range $265M - $270M
MT
09/16USANA HEALTH SCIENCES : Provides Preliminary Third Quarter Results and Updates F..
PU
09/16USANA HEALTH SCIENCES INC : Regulation FD Disclosure (form 8-K)
AQ
09/16USANA HEALTH SCIENCES : Provides Preliminary Third Quarter Results and Updates F..
BU
09/16USANA Health Sciences, Inc. Revises Earnings Guidance for the Full Year 2021
CI
09/16USANA Health Sciences, Inc. Provides Earnings Guidance for the Third Quarter ..
CI
09/15USANA : joint-support supplement earns third seal of approval
PR
08/31USANA HEALTH SCIENCES : 10 Ways to Build Resilience for September's Self-Improve..
PR
08/31USANA HEALTH SCIENCES : 10 Ways to Build Resilience for September's Self-Improve..
AQ
More news
Analyst Recommendations on USANA HEALTH SCIENCES, INC.
More recommendations
Financials (USD)
Sales 2021 1 193 M - -
Net income 2021 121 M - -
Net Debt 2021 - - -
P/E ratio 2021 14,9x
Yield 2021 -
Capitalization 1 779 M 1 779 M -
Capi. / Sales 2021 1,49x
Capi. / Sales 2022 1,47x
Nbr of Employees 1 943
Free-Float 60,0%
Chart USANA HEALTH SCIENCES, INC.
Duration : Period :
USANA Health Sciences, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends USANA HEALTH SCIENCES, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 88,92 $
Average target price 90,00 $
Spread / Average Target 1,21%
EPS Revisions
Managers and Directors
Kevin G. Guest Chairman & Chief Executive Officer
Jim Brown President
G. Douglas Hekking Chief Financial Officer
Myron W. Wentz Chairman-Emeritus
Robert Andrew Sinnott Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
USANA HEALTH SCIENCES, INC.15.33%1 779
BY-HEALTH CO., LTD.8.16%6 833
HERBALIFE NUTRITION LTD.-7.62%4 519
BALCHEM CORPORATION21.52%4 482
THE SIMPLY GOOD FOODS COMPANY10.36%3 350
MEDIFAST, INC.9.81%2 519